Publication | Closed Access

Combined use of WT1 and flow cytometry monitoring can promote sensitivity of predicting relapse after allogeneic HSCT without affecting specificity

Flow Cytometry MonitoringLymphoid NeoplasiaOncologyMedicineImmunologyHematologyPathologyImmunophenotypingCytopathologyAllogeneic HsctAdult T-cell Leukemia-lymphomaMolecular DiagnosticsRadiation OncologyCancer ResearchHealth Sciences